{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:54:51Z","timestamp":1740135291423,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T00:00:00Z","timestamp":1594425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T00:00:00Z","timestamp":1594425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Medical investigation is a favorite application of Ockham\u2019s razor, in virtue of which when presented with competing hypotheses, the solution with the fewest assumptions should be privileged. Hemolytic uremic syndrome (HUS) encompasses diseases with distinct pathological mechanisms, such as HUS due to shiga-like toxin-producing bacteria (STEC-HUS) and atypical HUS, linked to defects in the alternate complement pathway. Other etiologies such as Parvovirus B19 infection are exceptional. All these causes are rare to such extent that we usually consider them mutually exclusive. We report here two cases of HUS that could be traced to multiple causes.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Cases presentation<\/jats:title>\n<jats:p>Case 1 presented as vomiting and diarrhea. All biological characteristics of HUS were present. STEC was found in stool (by PCR and culture). After initial remission, a recurrence occurred and patient was started on Eculizumab. Genetic analysis revealed the heterozygous presence of a CFHR1\/CFH hybrid gene. The issue was favorable under treatment.<\/jats:p>\n<jats:p>In case 2, HUS presented as fever, vomiting and purpura of the lower limbs. Skin lesions and erythroblastopenia led to suspect Parvovirus B19 primo-infection, which was confirmed by peripheral blood and medullar PCR. Concurrently, stool culture and PCR revealed the presence of STEC. Evolution showed spontaneous recovery.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Both cases defy Ockham\u2019s razor in the sense that multiple causes could be traced to a single outcome; furthermore, they invite us to reflect on the physiopathology of HUS as they question the classical distinction between STEC-HUS and atypical HUS. We propose a two-hit mechanism model leading to HUS. Indeed, in case 1, HUS unfolded as a result of the synergistic interaction between an infectious trigger and a genetic predisposition. In case 2 however, it is the simultaneous occurrence of two infectious triggers that led to HUS. In dissent from Ockham\u2019s razor, an exceptional disease such as HUS may stem from the sequential occurrence or co-occurrence of several rare conditions.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12882-020-01926-2","type":"journal-article","created":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T11:02:22Z","timestamp":1594465342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ockham\u2019s razor defeated: about two atypical cases of hemolytic uremic syndrome"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4742-7939","authenticated-orcid":false,"given":"Chloe","family":"Schwarz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Brehon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyril","family":"Mousseaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosu","family":"Luque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Senet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna","family":"Mohamadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Zafrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Fr\u00e9meaux-Bacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Rondeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Buob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9dric","family":"Rafat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,11]]},"reference":[{"issue":"4","key":"1926_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00281-014-0416-x","volume":"36","author":"C Mele","year":"2014","unstructured":"Mele C, Remuzzi G, Noris M. Hemolytic uremic syndrome. Semin Immunopathol Juill. 2014;36(4):399\u2013420.","journal-title":"Semin Immunopathol Juill"},{"issue":"4","key":"1926_CR2","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2215\/CJN.04760512","volume":"8","author":"V Fremeaux-Bacchi","year":"2013","unstructured":"Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaim\u00e9 F, Dragon-Durey M-A, Ngo S, et al. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol. 2013;8(4):554\u201362.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1926_CR3","doi-asserted-by":"publisher","first-page":"bcr2015213492","DOI":"10.1136\/bcr-2015-213492","volume":"2016","author":"B Prasad","year":"2016","unstructured":"Prasad B, St Onge J. Parvovirus leading to thrombotic microangiopathy in a healthy adult. BMJ Case Rep. 2016;2016:bcr2015213492.","journal-title":"BMJ Case Rep"},{"issue":"2","key":"1926_CR4","first-page":"137","volume":"6","author":"MR Ardalan","year":"2008","unstructured":"Ardalan MR, Shoja MM, Tubbs RS, Jayne D. Parvovirus B19 microepidemic in renal transplant recipients with thrombotic microangiopathy and allograft vasculitis. Exp Clin Transplant. 2008;6(2):137\u201343.","journal-title":"Exp Clin Transplant"},{"issue":"6","key":"1926_CR5","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1053\/j.ajkd.2005.03.010","volume":"45","author":"A Subramanya","year":"2005","unstructured":"Subramanya A, Houghton D, Watnick S. Steroid-responsive idiopathic glomerular capillary endotheliosis: case report and literature review. Am J Kidney Dis. 2005;45(6):1090\u20135.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1926_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1681\/ASN.2013121339","volume":"26","author":"E Valoti","year":"2015","unstructured":"Valoti E, Alberti M, Tortajada A, Garcia-Fernandez J, Gastoldi S, Besso L, et al. A novel atypical hemolytic uremic syndrome\u2013associated hybrid CFHR1\/CFH gene encoding a fusion protein that antagonizes factor H\u2013dependent complement regulation. J Am Soc Nephrol. 2015;26(1):209\u201319.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"1926_CR7","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1681\/ASN.2018070759","volume":"29","author":"F Bu","year":"2018","unstructured":"Bu F, Zhang Y, Wang K, Borsa NG, Jones MB, Taylor AO, et al. Genetic analysis of 400 patients refines understanding and implicates a new gene in atypical hemolytic uremic syndrome. J Am Soc Nephrol. 2018;29(12):2809\u201319.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"1926_CR8","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneph.2012.195","volume":"8","author":"M Noris","year":"2012","unstructured":"Noris M, Mescia F, Remuzzi G. STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol. 2012;8(11):622\u201333.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"1926_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.molimm.2013.11.009","volume":"58","author":"K Poolpol","year":"2014","unstructured":"Poolpol K, Orth-H\u00f6ller D, Speth C, Zipfel PF, Skerka C, de C\u00f3rdoba SR, et al. Interaction of Shiga toxin 2 with complement regulators of the factor H protein family. Mol Immunol. 2014;58(1):77\u201384.","journal-title":"Mol Immunol"},{"issue":"1","key":"1926_CR10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4049\/jimmunol.1100491","volume":"187","author":"M Morigi","year":"2011","unstructured":"Morigi M, Galbusera M, Gastoldi S, Locatelli M, Buelli S, Pezzotta A, et al. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. J Immunol. 2011;187(1):172\u201380.","journal-title":"J Immunol"},{"issue":"2","key":"1926_CR11","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1182\/blood-2007-04-084533","volume":"111","author":"CJ Fang","year":"2008","unstructured":"Fang CJ, Fremeaux-Bacchi V, Liszewski MK, Pianetti G, Noris M, Goodship THJ, et al. Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood. 2008;111(2):624\u201332.","journal-title":"Blood."},{"issue":"1","key":"1926_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00467-015-3207-2","volume":"31","author":"C Caillaud","year":"2016","unstructured":"Caillaud C, Zaloszyc A, Licht C, Pichault V, Fr\u00e9meaux-Bacchi V, Fischbach M. CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS). Pediatr Nephrol. 2016;31(1):157\u201361.","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"1926_CR13","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1111\/ajt.12297","volume":"13","author":"M Alberti","year":"2013","unstructured":"Alberti M, Valoti E, Piras R, Bresin E, Galbusera M, Tripodo C, et al. Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations. Am J Transplant. 2013;13(8):2201\u20136.","journal-title":"Am J Transplant"},{"issue":"3","key":"1926_CR14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2215\/CJN.05830518","volume":"14","author":"V Fr\u00e9meaux-Bacchi","year":"2019","unstructured":"Fr\u00e9meaux-Bacchi V, Sellier-Leclerc AL, Vieira-Martins P, Limou S, Kwon T, Lahoche A, et al. Complement gene variants and Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome: retrospective genetic and clinical study. Clin J Am Soc Nephrol. 2019;14(3):364\u201377.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 1","key":"1926_CR15","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.2215\/CJN.01060307","volume":"2","author":"M Waldman","year":"2007","unstructured":"Waldman M, Kopp JB. Parvovirus B19 and the kidney. Clin J Am Soc Nephrol. 2007;2(Suppl 1):S47\u201356.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"1926_CR16","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1681\/ASN.V1161132","volume":"11","author":"L Murer","year":"2000","unstructured":"Murer L, Zacchello G, Bianchi D, et al. Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation. J Am Soc Nephrol. 2000;11(6):1132\u20137.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1926_CR17","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/infdis\/172.5.1198","volume":"172","author":"LL Cooling","year":"1995","unstructured":"Cooling LL, Koerner TA, Naides SJ. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J Infect Dis. 1995;172(5):1198\u2013205.","journal-title":"J Infect Dis"},{"issue":"3","key":"1926_CR18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1159\/000046086","volume":"89","author":"S Takeda","year":"2001","unstructured":"Takeda S, Takaeda C, Takazakura E, Haratake J. Renal involvement induced by human parvovirus B19 infection. Nephron. 2001;89(3):280\u20135.","journal-title":"Nephron."}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01926-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-01926-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01926-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T23:21:23Z","timestamp":1625959283000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-01926-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,11]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1926"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-01926-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2020,7,11]]},"assertion":[{"value":"7 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent was obtained from both patients before publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"269"}}